Increased expression of interleukin-4 receptors on psoriatic epidermal cells

American Journal of Pathology

Volumn 148, Issue 5, 1996, Pages 1493-1502

  Prens, Errol ^a,b   Hegmans, Joost ^a   Lien, Roël Chin A ^a   Debets, Reno ^a   Troost, Roger ^a   Van Joost, Theodoor ^a   Benner, Robbert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4 RECEPTOR;

ADULT; ARTICLE; BINDING SITE; CELL PROLIFERATION; CLINICAL ARTICLE; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KERATINOCYTE; MALE; PRIORITY JOURNAL; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; BIOPSY; CELL DIVISION; CELLS, CULTURED; EPIDERMIS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PSORIASIS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-4; RNA, MESSENGER;

EID: 0029965467     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ, Fisher G: IL-1 activity is reduced in psoriatic skin: decreased IL-1α and increased nonfunctional IL-1β J Immunol 1990, 144: 4593-4603
2. Gearing AJ, Fincham NJ, Bird CR, Wadhwa M, Meager A, Cartwright JE, Camp RD: Cytokines in skin lesions of psoriasis Cytokine 1990, 2:68-75
3. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb A: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989, 86:6367-6371
4. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ Keratinocytes as initiators of inflammation Lancet 1991 337:211-214
5. Krueger JG, Krane JF, Carter DM, Gottlieb AB: Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis J Invest Dermatol 1990 94 135S-140S
6. Baadsgaard O, Tong P, Elder JT, Hansen ER, Ho V, Hammerberg C, Lange-Vejlsgaard G, Fox DA, Fisher G, Chan LS, Voorhees JJ, Cooper KD UM4D4 (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. J Invest Dermatol 1990, 95:275-282
7. Gottlieb AB, Luster AD, Posnett DN, Carter DM Detection of a γ interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 1989, 168:941-948
8. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705
9. Scheynius A, Fransson J, Johansson C, Hammar H, Baker B, Fry L, Valdimarsson H: Expression of interferon-γ receptors in normal and psoriatic skin. J Invest Dermatol 1992, 98:255-258
10. Kristensen M, Deleuran B, Eady DJ, Feldmann M, Breatnach SM, Brennan FM: Distribution of interleukin 1 receptor antagonist protein, interleukin 1 receptor, and interleukin 1α in normal and psoriatic skin, decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 1992, 127:305-311
11. Groves RW, Sherman L, Mizutani H, Dower SK, Kupper TS Detection of interleukin 1 receptors in human epidermis induction of the type II receptor after organ culture and in psoriasis Am J Pathol 1994, 94:1048-1056
12. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL: Two types of murine helper T cell clones: definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357
13. Foxwell BMJ, Woerly G, Ruffel B: Identification of interleukin 4 receptor-associated proteins and expression of both high and low-affinity binding on human lymphoid cells. Eur J Immunol 1989, 85 8221-8225
14. Lowenthal JW, Castle BE, Christiansen J, Schreurs J, Rennick D, Arai N, Hoy P, Tabeke Y, Howard M: Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hematopoietic and nonhematopoietic cells. J Immunol 1988, 140:456-464
15. Mat I, Larché M, Melcher D, Ritter MA: Tumour-associated upregulation of the IL-4 receptor complex Br J Cancer (Suppl) 1990, 10:96-98
16. Obiri NI, Siegel JP, Varricchio F, Puri RK Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells Clin Exp Immunol 1994, 95:148-155
17. - antigen-presenting cells J Invest Dermatol 1991, 96:880-887
18. Rotman B, Papermaster BW: Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters Proc Natl Acad Sci USA 1966, 55 134-139
19. Van Dongen JJM, Adriaansen HJ, Hooijkaas H: Immunological marker analysis of cells in the various hematopoietic differentiation stages and their malignant counterparts. Application of Monoclonal Antibodies in Tumor Pathology. Edited by DJ Ruiter, J Fleuren, SO Warnaar. Dordrecht, The Netherlands, M Nijhoff, 1987
20. Van Joost T, Kozel MMA, Tank B, Troost R, Prens EP: Cyclosporine in atopic dermatitis: modulation in the expression of immunologic markers in lesional skin J Am Acad Dermatol 1992, 27 922-928
21. Sharrow SO: Immunofluorescence and cell sorting. Current Protocols in Immunology. Edited by JE Coligan, AM Kruisbeek, DH Margulies, E Shevach, W Strober New York, Greene Publishing and Wiley Interscience, 1991, Units 5 2 and 5.7
22. Kumagai KT, Abo T, Sekizawa T, Sasaki M: Dissociation of cell-bound immunoglobulins with acid pH or at 37°C. J Immunol 1975, 115:982-986
23. Muegge K, Durum SK: Cytokines and their cellular receptors. Current Protocols in Immunology. Edited by JE Coligan, AM Kruisbeek, DH Margulies, EM Shevach, W Strober. New York, Greene Publishing and Wiley Interscience, 1991, Unit 6.1
24. Idzerda RL, March CJ, Mosley B, Lyman SD, Vanden Bos T, Gimpel SD, Din WS, Grabstein KH, Widmer MB, Park LS: Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990, 171:861-873
25. Cox KH, DeLeon DV, Angerer LM, Angerer RC: Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 1984, 101:485-502
26. De Block M, Debrouwer D: RNA-RNA in situ hybridization using digoxigenin-labeled probes: the use of high molecular weight polyvinyl alcohol in the alkaline phosphatase indoxyl-nitroblue tetrazolium reaction Anal Biochem 1993, 215:86-89
27. Bata-Csorgo Zs, Hammerberg C, Voorhees JJ, Cooper KD: Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993, 178:1271-1281
28. Blanton RA, Kupper TS, McDougall JK, Dower S: Regulation of interleukin 1 and its receptor in human keratinocytes Proc Natl Acad Sci USA 1989, 86:1273-1277
29. 125I-epidermal growth factor binding and receptor distribution in psoriasis. J Invest Derrnatol 1986, 86:260-265
30. Alkemade JAC, Molhuizen HOF, Van Vlijmen-Willems IMJJ, Van Haelst UJGM, Schalkwijk J: Differential expression of SKALP/elafin in human epidermal tumors Am J Pathol 1993, 143:1679-1687
31. Mozo L, Rivas D, Zamorano J, Gutierrez C: Differential expression of IL-4 receptors in human T and B lymphocytes. J Immunol 1993, 150:4261-4269
32. Schlaak JF, Buslau M, Jochum V, Hermann E, Girrndt M, Gallati H T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994, 102: 145-149
33. Feldman GM, Ruhl S, Bikel M, Finbloom DS, Pluznik DH: Regulation of interleukin-4 receptors on murine myeloid progenitor cells by interleukin-6 Blood 1991, 78 1678-1675
34. Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 displays potent anti-tumor activity. Cell 1989, 57:503-512
35. Carter KC, Gallagher G, Baillie AJ, Alexander J: The induction of protective immunity to Leishmania major in the Balb/c mouse by interleukin-4 treatment. Eur J Immunol 1989, 19:779-782
36. 2. Proc Natl Acad Sci USA 1989, 86:3803-3807
37. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475
38. Vannier E, Miller LC, Dinarello CA: Coordinated anti-inflammatory effects of interleukin-4. interleukin-4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist. Proc Natl Acad Sci USA 1992, 89:4076-4080
39. Debets JEMA, Hegmans JPJJ, Benner R, Prens EP: Psoriatic epidermal cells secrete biologically active IL-1α and IL-1β ex vivo: evidence of facilitated IL-1 release and elevated cytoplasmic IL-1β levels Eur J Immunol 1995, 25:1624-1630